» Articles » PMID: 35030965

Paeoniflorin Alleviates NG-nitro-L-arginine Methyl Ester (L-NAME)-induced Gestational Hypertension and Upregulates Silent Information Regulator 2 Related Enzyme 1 (SIRT1) to Reduce HO-induced Endothelial Cell Damage

Overview
Journal Bioengineered
Date 2022 Jan 15
PMID 35030965
Authors
Affiliations
Soon will be listed here.
Abstract

Pregnancy-induced hypertension (PIH) is a leading cause of maternal mortality. Paeoniflorin has been reported to alleviate hypertension, thus relieving the injury of target organ. This study aimed to investigate the role of paeoniflorin in PIH development by regulating SIRT1 in rats. The mean arterial pressure (MAP), urine protein and histopathological damage of placenta in gestational hypertension rats were, respectively, detected by noninvasive tail-artery pressure measuring instrument, BCA method and H&E staining. The viability of human umbilical vein endothelial cells (HUVECs) treated with paeoniflorin or/and HO was observed by CCK-8 assay. SIRT1 protein expression in HUVECs treated with paeoniflorin or/and HO was analyzed by Western blot. Tunel assay, wound healing assay and tube formation assay were used to detect the apoptosis, migration and tube formation of HUVECs administrated with paeoniflorin or/and HO or/and EX527 (SIRT1 inhibitor). As a result, MAP, urine protein and histopathological damage of placenta were enhanced in PIH rats, which were then alleviated by paeoniflorin. Paeoniflorin decreased the levels of sFlt-1, PlGF and VEGF in serum and placental tissues of gestational hypertension rats as well as the inflammatory response and oxidative stress. In addition, paeoniflorin promoted the expressions of SIRT1 and NO/eNOS and inhibited the production of iNOS in gestational hypertension rats to improve vascular endothelial cell injury. However, SIRT1 inhibition could suppress the protective effects of paeoniflorin on endothelial dysfunction of HO-induced HUVECs. In conclusion, paeoniflorin could improve gestational hypertension development by upregulating SIRT1.

Citing Articles

Changes of maternal carotid artery elasticity in patients with pregnancy concurred with hypertension.

Lan Q, Liu S, He Q, Li Y Arch Gynecol Obstet. 2025; .

PMID: 39907747 DOI: 10.1007/s00404-025-07941-8.


Expression of long non-coding RNA GAS5 by first trimester screening predicts the occurrence of gestational hypertension and pre-eclampsia.

Wang L, Chen J, Li H, Zhou Q, Zhang C J Assist Reprod Genet. 2024; 41(6):1661-1667.

PMID: 38530512 PMC: 11224183. DOI: 10.1007/s10815-024-03093-x.


Natural Monoterpenes as Potential Therapeutic Agents against Atherosclerosis.

Yang J, Zhong C, Yu J Int J Mol Sci. 2023; 24(3).

PMID: 36768748 PMC: 9917110. DOI: 10.3390/ijms24032429.


Therapeutic potential of paeoniflorin in atherosclerosis: A cellular action and mechanism-based perspective.

Yu W, Ilyas I, Hu X, Xu S, Yu H Front Immunol. 2023; 13:1072007.

PMID: 36618414 PMC: 9811007. DOI: 10.3389/fimmu.2022.1072007.


Leukotriene Receptor Antagonist, Montelukast Ameliorates L-NAME-Induced Pre-eclampsia in Rats through Suppressing the IL-6/Jak2/STAT3 Signaling Pathway.

Abdelzaher W, Mostafa-Hedeab G, Bahaa H, Mahran A, Fawzy M, Abdel Hafez S Pharmaceuticals (Basel). 2022; 15(8).

PMID: 35893738 PMC: 9332684. DOI: 10.3390/ph15080914.


References
1.
Zhong S, Ge Q, Li Q, Qu R, Ma S . Peoniflorin attentuates Abeta((1-42))-mediated neurotoxicity by regulating calcium homeostasis and ameliorating oxidative stress in hippocampus of rats. J Neurol Sci. 2009; 280(1-2):71-8. DOI: 10.1016/j.jns.2009.01.027. View

2.
Visintin C, Mugglestone M, Almerie M, Nherera L, James D, Walkinshaw S . Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ. 2010; 341:c2207. DOI: 10.1136/bmj.c2207. View

3.
Xu K, Zang X, Peng M, Zhao Q, Lin B . Magnesium Lithospermate B Downregulates the Levels of Blood Pressure, Inflammation, and Oxidative Stress in Pregnant Rats with Hypertension. Int J Hypertens. 2020; 2020:6250425. PMC: 7519462. DOI: 10.1155/2020/6250425. View

4.
Liu X, Chen K, Zhuang Y, Huang Y, Sui Y, Zhang Y . Paeoniflorin improves pressure overload-induced cardiac remodeling by modulating the MAPK signaling pathway in spontaneously hypertensive rats. Biomed Pharmacother. 2019; 111:695-704. DOI: 10.1016/j.biopha.2018.12.090. View

5.
Chong Z, Wang S, Shang Y, Maiese K . Targeting cardiovascular disease with novel SIRT1 pathways. Future Cardiol. 2011; 8(1):89-100. PMC: 3254055. DOI: 10.2217/fca.11.76. View